In patients with Lyme neuroborreliosis, inflammation and symptoms of f
atigue and malaise occur out of proportion to the relatively low numbe
r of spirochetes present. Previous studies have identified interleukin
-6 (IL-6) as a candidate molecule for amplification of CNS inflammatio
n in this disease. We pursued this possibility by measuring cytokine g
ene expression by reverse-transcriptase polymerase chain reaction (RT-
PCR) in the brain of rhesus macaques actively infected with Borrelia b
urgdorferi. Samples of brain tissue were screened for IL-6 and interfe
ron gamma using RT-PCR-ELISA, a technique that uses RT-PCR, subsequent
hybridization of the PCR product with a biotinylated probe, and captu
re and ELISA readout of hybridization product. The number of copies in
positive samples was then quantitated using qRT-PCR-ELISA, in which w
ild-type cytokine cDNA competes with recombinant competitor DNA in the
PCR. Elevated levels of IL-6 cDNA and, to a lesser extent, interferon
gamma were detected in three of three nonhuman primates with persiste
nt infection with B burgdorferi, whereas the brains of three uninfecte
d animals had undetectable levels of gene expression of these cytokine
s. These data support the hypothesis that cytokines such as IL-6 are i
mportant amplification molecules for CNS inflammation in Lyme neurobor
reliosis.